GH Research (GHRS) News Today $13.96 +0.17 (+1.23%) As of 01:31 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GHRS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Analysts Issue Forecasts for GH Research FY2026 EarningsJune 12 at 3:03 AM | americanbankingnews.comGH Research (NASDAQ:GHRS) Shares Down 4.6% - What's Next?GH Research (NASDAQ:GHRS) Trading Down 4.6% - What's Next?June 10 at 3:48 PM | marketbeat.comCantor Fitzgerald Predicts GH Research FY2026 EarningsGH Research PLC (NASDAQ:GHRS - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for GH Research in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst C. Duncan forecasts that the company will earn ($1.72) per share for the year. Cantor FJune 10 at 8:57 AM | marketbeat.comGH Research (NASDAQ:GHRS) Trading 8.3% Higher - What's Next?GH Research (NASDAQ:GHRS) Shares Up 8.3% - Here's WhyJune 9 at 3:31 PM | marketbeat.comGH Research (NASDAQ:GHRS) Now Covered by Analysts at Cantor FitzgeraldJune 6, 2025 | americanbankingnews.comCantor Fitzgerald Initiates Coverage of GH Research (GHRS) With Overweight RatingJune 5, 2025 | insidermonkey.comGH Research (NASDAQ:GHRS) Now Covered by Cantor FitzgeraldCantor Fitzgerald started coverage on shares of GH Research in a research report on Wednesday. They set an "overweight" rating and a $25.00 target price on the stock.June 4, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Trading 4.1% Higher - Still a Buy?GH Research (NASDAQ:GHRS) Stock Price Up 4.1% - What's Next?May 30, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Down 4% - Should You Sell?GH Research (NASDAQ:GHRS) Stock Price Down 4% - Here's What HappenedMay 30, 2025 | marketbeat.comWoodline Partners LP Increases Position in GH Research PLC (NASDAQ:GHRS)Woodline Partners LP boosted its holdings in GH Research PLC (NASDAQ:GHRS - Free Report) by 112.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 78,949 shares of the company's stock after purchasing an additional 41,711 shares duringMay 28, 2025 | marketbeat.comGH Research to Present at ASCP Meeting on Breakthrough Depression TreatmentMay 27, 2025 | tipranks.comGH Research PLC (NASDAQ:GHRS) Receives Consensus Recommendation of "Buy" from BrokeragesShares of GH Research PLC (NASDAQ:GHRS - Get Free Report) have received a consensus recommendation of "Buy" from the seven analysts that are presently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation and one has assigned a strongMay 23, 2025 | marketbeat.comCantor Fitzgerald Upgrades GH Research (NASDAQ:GHRS) to "Strong-Buy"Cantor Fitzgerald raised GH Research to a "strong-buy" rating in a report on Tuesday.May 17, 2025 | marketbeat.comCantor Fitzgerald Expects Lower Earnings for GH ResearchGH Research PLC (NASDAQ:GHRS - Free Report) - Equities researchers at Cantor Fitzgerald reduced their FY2025 EPS estimates for GH Research in a research report issued on Monday, May 12th. Cantor Fitzgerald analyst C. Duncan now expects that the company will post earnings of ($0.84) per share forMay 16, 2025 | marketbeat.comGH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual MeetingMay 15, 2025 | globenewswire.comGH Research (NASDAQ:GHRS) Earns "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $40.00 price objective on shares of GH Research in a report on Friday.May 11, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), GH Research (GHRS) and NewAmsterdam Pharma Company (NAMS)May 11, 2025 | theglobeandmail.comPsychedelic: Compass, GH Research, MindMed report quarterly earningsMay 9, 2025 | finance.yahoo.comGH Research PLC: GH Research Reports First Quarter 2025 Financial Results and Provides Business UpdatesMay 8, 2025 | finanznachrichten.deGH Research Reports First Quarter 2025 Financial Results and Provides Business UpdatesMay 8, 2025 | globenewswire.comLynx1 Capital Management LP Buys 663,100 Shares of GH Research PLC (NASDAQ:GHRS)Lynx1 Capital Management LP lifted its stake in GH Research PLC (NASDAQ:GHRS - Free Report) by 15.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,858,994 shares of the company's stock after purchasing an additional 663,100 shares durApril 29, 2025 | marketbeat.comGH Research PLC (NASDAQ:GHRS) Given Average Rating of "Buy" by AnalystsGH Research PLC (NASDAQ:GHRS - Get Free Report) has been assigned a consensus recommendation of "Buy" from the seven brokerages that are covering the firm, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokApril 28, 2025 | marketbeat.comGH Research (GHRS) to Release Quarterly Earnings on FridayGH Research (NASDAQ:GHRS) will be releasing its Q1 2025 earnings before the market opens on Friday, May 2. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-2-gh-research-plc-stock/)April 27, 2025 | marketbeat.comDiadema Partners LP Purchases Shares of 101,502 GH Research PLC (NASDAQ:GHRS)Diadema Partners LP purchased a new stake in GH Research PLC (NASDAQ:GHRS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 101,502 shares of the company's stock, valued at approximately $711,000.April 24, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Sees Large Volume Increase - Should You Buy?GH Research (NASDAQ:GHRS) Sees Strong Trading Volume - Here's What HappenedApril 4, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Down 7.4% - Here's What HappenedGH Research (NASDAQ:GHRS) Shares Down 7.4% - Here's What HappenedMarch 29, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Up 4.9% - Time to Buy?GH Research (NASDAQ:GHRS) Trading 4.9% Higher - Still a Buy?March 28, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Up 7% - Still a Buy?GH Research (NASDAQ:GHRS) Trading 7% Higher - Here's What HappenedMarch 20, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Down 3.5% - Here's What HappenedGH Research (NASDAQ:GHRS) Trading Down 3.5% - Should You Sell?March 18, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Gap Up - Here's What HappenedGH Research (NASDAQ:GHRS) Shares Gap Up - Still a Buy?March 14, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Now Covered by Analysts at GuggenheimGuggenheim started coverage on shares of GH Research in a research note on Thursday. They issued a "buy" rating and a $32.00 price target on the stock.March 14, 2025 | marketbeat.comGH Research initiated with a Buy at GuggenheimMarch 12, 2025 | markets.businessinsider.comGuggenheim starts GH Research at Buy, sees long-term upside potentialMarch 12, 2025 | markets.businessinsider.comGH Research (NASDAQ:GHRS) Shares Up 6.7% - Time to Buy?GH Research (NASDAQ:GHRS) Trading Up 6.7% - What's Next?March 11, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Gap Up - Still a Buy?GH Research (NASDAQ:GHRS) Shares Gap Up - Should You Buy?March 8, 2025 | marketbeat.comGH Research PLC (NASDAQ:GHRS) Receives Average Rating of "Buy" from AnalystsShares of GH Research PLC (NASDAQ:GHRS - Get Free Report) have been given an average rating of "Buy" by the six ratings firms that are covering the company, Marketbeat reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that haveMarch 8, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Coverage Initiated by Analysts at Royal Bank of CanadaRoyal Bank of Canada began coverage on shares of GH Research in a research note on Friday. They issued an "outperform" rating and a $31.00 price target on the stock.March 8, 2025 | marketbeat.comHC Wainwright Has Optimistic View of GH Research Q1 EarningsGH Research PLC (NASDAQ:GHRS - Free Report) - Equities researchers at HC Wainwright upped their Q1 2025 earnings estimates for shares of GH Research in a research report issued to clients and investors on Tuesday, March 4th. HC Wainwright analyst P. Trucchio now forecasts that the company will poMarch 8, 2025 | marketbeat.comRBC Capital Initiates Coverage of GH Research (GHRS) with Outperform RecommendationMarch 8, 2025 | msn.comShort Interest in GH Research PLC (NASDAQ:GHRS) Rises By 21.1%GH Research PLC (NASDAQ:GHRS - Get Free Report) was the recipient of a significant growth in short interest in February. As of February 15th, there was short interest totalling 2,870,000 shares, a growth of 21.1% from the January 31st total of 2,370,000 shares. Based on an average daily trading volume, of 404,900 shares, the days-to-cover ratio is presently 7.1 days. Currently, 7.9% of the company's stock are sold short.March 7, 2025 | marketbeat.comFY2029 EPS Estimates for GH Research Raised by HC WainwrightGH Research PLC (NASDAQ:GHRS - Free Report) - Stock analysts at HC Wainwright raised their FY2029 EPS estimates for shares of GH Research in a research note issued to investors on Tuesday, March 4th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn $0.13 per share forMarch 7, 2025 | marketbeat.comGH Research initiated with an Outperform at RBC CapitalMarch 7, 2025 | markets.businessinsider.comCantor Fitzgerald Raises Earnings Estimates for GH ResearchGH Research PLC (NASDAQ:GHRS - Free Report) - Investment analysts at Cantor Fitzgerald lifted their FY2025 earnings per share estimates for GH Research in a research note issued to investors on Tuesday, March 4th. Cantor Fitzgerald analyst C. Duncan now anticipates that the company will earn ($0.March 7, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Sees Strong Trading Volume - Still a Buy?GH Research (NASDAQ:GHRS) Sees Unusually-High Trading Volume - What's Next?March 6, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Trading 5.9% Higher - Still a Buy?GH Research (NASDAQ:GHRS) Trading 5.9% Higher - What's Next?March 5, 2025 | marketbeat.comGH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025March 1, 2025 | insidermonkey.comGH Research (NASDAQ:GHRS) Announces Quarterly Earnings ResultsGH Research (NASDAQ:GHRS - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.06.February 28, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Given New $32.00 Price Target at Stifel NicolausStifel Nicolaus upped their target price on GH Research from $18.00 to $32.00 and gave the company a "buy" rating in a report on Thursday.February 28, 2025 | marketbeat.comGH Research PLC: GH Research Reports Full Year 2024 Financial Results and Provides Business UpdatesFebruary 27, 2025 | finanznachrichten.dePsychedelic: GH Research, Compass Pathways report earnings resultsFebruary 27, 2025 | markets.businessinsider.com Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address GHRS Media Mentions By Week GHRS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GHRS News Sentiment▼0.980.87▲Average Medical News Sentiment GHRS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GHRS Articles This Week▼93▲GHRS Articles Average Week Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Apellis Pharmaceuticals News Organon & Co. News HUTCHMED News ImmunityBio News Amneal Pharmaceuticals News Xenon Pharmaceuticals News Mirum Pharmaceuticals News Arrowhead Pharmaceuticals News Ascentage Pharma Group International News NewAmsterdam Pharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GHRS) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GH Research PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share GH Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.